Scott's Liquid Gold - Inc. - Quarter Report: 2020 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2020
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-13458
SCOTT’S LIQUID GOLD-INC.
(Exact name of registrant as specified in its charter)
Colorado |
|
84-0920811 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
8400 E. Crescent Parkway, Suite 450, Greenwood Village, CO |
|
80111 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (303) 373-4860
Securities registered pursuant to Section 12(b) of the Exchange Act.
Title of each class |
|
Trading Symbol |
|
Name of exchange on which registered |
None |
|
None |
|
None |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
||||
|
|
|
|
|||||||
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
||||
|
|
|
|
|
|
|
||||
Emerging growth company |
|
☐ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of August 3, 2020, the registrant had 12,461,963 shares of its common stock, $0.10 par value per share, outstanding.
CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION
This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, in addition to historical information. All statements, other than statements of historical facts, included in this Report that address activities, events, or developments with respect to our financial condition, results of operations, or economic performance that we expect, believe, or anticipate will or may occur in the future, or that address plans and objectives of management for future operations, are forward-looking statements. You can typically identify forward-looking statements by the use of words, such as “may,” “could,” “should,” “assume,” “project,” “believe,” “anticipate,” “expect,” “estimate,” “potential,” “plan,” and other similar words. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
The forward-looking statements contained in this Report are based on management’s current expectations and are subject to uncertainty and changes in circumstances. We cannot assure you that future developments affecting us will be those that we have anticipated. Forward-looking statements and our performance inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to:
|
• |
duration and scope of the COVID-19 pandemic, government and other third-party responses to it and the consequences for the global economy, including to our business, employees, and the businesses of our suppliers, customers and manufacturers of our distributed products; |
|
• |
dependence on third-party vendors and on sales to major customers; |
|
• |
regulations, economic conditions, and tariffs in the People’s Republic of China (“PRC”), as well as dependence on the efforts of our exclusive distributor in the PRC to market and sell our products there; |
|
• |
continuation of our distributorship agreement for Batiste Dry Shampoos; |
|
• |
a continued shift in the retail market from food and drug stores to mass merchandisers, club stores, dollar stores, e-commerce retailers, and subscription services; |
|
• |
competition from large consumer products companies in the United States; |
|
• |
competitive factors, including any decrease in distribution of (i.e., retail stores carrying) our significant products; |
|
• |
new competitive products and/or technological changes; |
|
• |
the need for effective advertising of our products and limited resources available for such advertising; |
|
• |
unfavorable economic conditions; |
|
• |
changing consumer preferences and the continued acceptance of each of our significant products in the marketplace; |
|
• |
the degree of success of any new product or product line introduction by us; |
|
• |
the degree of success of the integration of product lines or businesses we may acquire; |
|
• |
the degree of success of our conversion to outsourced manufacturing and dependence on third-party manufacturers; |
|
• |
the availability of necessary raw materials and potential increases in the prices of these raw materials; |
|
• |
changes in the regulation of our products, including applicable environmental, U.S. and international Food and Drug Administration regulations and process-audit compliance; |
|
• |
the loss of any executive officer or other personnel; |
|
• |
future losses which could affect our liquidity; |
|
• |
other matters discussed in this Report, including the risks described in the Risk Factors section of this Report and in our Annual Report on Form 10-K for the year ended December 31, 2019 and subsequent Quarterly Reports on Form 10-Q. |
We caution you that forward-looking statements are not guarantees of future performance and that actual results or performance may be materially different from those expressed or implied in the forward-looking statements. The forward-looking statements in this Report speak as of the filing date of this Report. Although we may from time to time voluntarily update our prior forward-looking statements, we undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this Report.
|
|
|
Page |
|
|
||
Item 1. |
|
1 |
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
16 |
Item 3. |
|
22 |
|
Item 4. |
|
22 |
|
|
|
||
Item 1A. |
|
23 |
|
Item 6. |
|
23 |
SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share data)
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
June 30, |
|
|
June 30, |
|
||||||||||
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
||||
Net sales |
$ |
6,083 |
|
|
$ |
6,382 |
|
|
$ |
13,937 |
|
|
$ |
13,187 |
|
Cost of sales |
|
3,215 |
|
|
|
4,442 |
|
|
|
7,605 |
|
|
|
8,642 |
|
Gross Profit |
|
2,868 |
|
|
|
1,940 |
|
|
|
6,332 |
|
|
|
4,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising |
|
141 |
|
|
|
202 |
|
|
|
362 |
|
|
|
386 |
|
Selling |
|
1,614 |
|
|
|
1,354 |
|
|
|
3,203 |
|
|
|
3,012 |
|
General and administrative |
|
1,503 |
|
|
|
1,158 |
|
|
|
2,907 |
|
|
|
2,381 |
|
Total operating expenses |
|
3,258 |
|
|
|
2,714 |
|
|
|
6,472 |
|
|
|
5,779 |
|
Loss from operations |
|
(390 |
) |
|
|
(774 |
) |
|
|
(140 |
) |
|
|
(1,234 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
2 |
|
|
|
30 |
|
|
|
3 |
|
|
|
61 |
|
Interest expense |
|
(74 |
) |
|
|
(4 |
) |
|
|
(78 |
) |
|
|
(9 |
) |
Gain on sale of equipment |
|
- |
|
|
|
110 |
|
|
|
- |
|
|
|
110 |
|
Income from distribution agreement termination |
|
350 |
|
|
|
- |
|
|
|
350 |
|
|
|
- |
|
Loss before income taxes |
|
(112 |
) |
|
|
(638 |
) |
|
|
135 |
|
|
|
(1,072 |
) |
Income tax benefit (expense) |
|
34 |
|
|
|
(78 |
) |
|
|
64 |
|
|
|
26 |
|
Net (loss) income |
$ |
(78 |
) |
|
$ |
(716 |
) |
|
$ |
199 |
|
|
$ |
(1,046 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.01 |
) |
|
$ |
(0.06 |
) |
|
$ |
0.02 |
|
|
$ |
(0.08 |
) |
Diluted |
$ |
(0.01 |
) |
|
$ |
(0.06 |
) |
|
$ |
0.02 |
|
|
$ |
(0.08 |
) |
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
12,462 |
|
|
|
12,436 |
|
|
|
12,462 |
|
|
|
12,422 |
|
Diluted |
|
12,462 |
|
|
|
12,436 |
|
|
|
12,571 |
|
|
|
12,422 |
|
See accompanying notes to these Condensed Consolidated Financial Statements (Unaudited).
1
SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except par value amounts)
|
June 30, |
|
|
December 31, |
|
||
|
2020 |
|
|
2019 |
|
||
|
(Unaudited) |
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
5,877 |
|
|
$ |
1,094 |
|
Accounts receivable, net |
|
2,539 |
|
|
|
2,695 |
|
Inventories, net |
|
4,936 |
|
|
|
7,841 |
|
Income taxes receivable |
|
383 |
|
|
|
705 |
|
Property and equipment held for sale |
|
- |
|
|
|
500 |
|
Prepaid expenses |
|
429 |
|
|
|
368 |
|
Other current assets |
|
- |
|
|
|
71 |
|
Total current assets |
|
14,164 |
|
|
|
13,274 |
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
133 |
|
|
|
124 |
|
Deferred tax asset |
|
491 |
|
|
|
556 |
|
Goodwill |
|
3,230 |
|
|
|
3,230 |
|
Intangible assets, net |
|
8,271 |
|
|
|
8,719 |
|
Operating lease right-of-use assets |
|
3,112 |
|
|
|
188 |
|
Other assets |
|
180 |
|
|
|
- |
|
Total assets |
$ |
29,581 |
|
|
$ |
26,091 |
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable |
$ |
1,636 |
|
|
$ |
1,809 |
|
Accrued expenses |
|
745 |
|
|
|
422 |
|
Operating lease liabilities, current portion |
|
116 |
|
|
|
197 |
|
Total current liabilities |
|
2,497 |
|
|
|
2,428 |
|
|
|
|
|
|
|
|
|
Operating lease liabilities, net of current |
|
3,127 |
|
|
|
19 |
|
Other liabilities |
|
70 |
|
|
|
27 |
|
Total liabilities |
|
5,694 |
|
|
|
2,474 |
|
|
|
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
Preferred stock, no par value, authorized 20,000 shares; no shares issued and outstanding |
|
- |
|
|
|
- |
|
Common stock; $0.10 par value, authorized 50,000 shares; issued and outstanding 12,462 shares (2020) and 12,462 shares (2019) |
|
1,246 |
|
|
|
1,246 |
|
Capital in excess of par |
|
7,321 |
|
|
|
7,250 |
|
Retained earnings |
|
15,320 |
|
|
|
15,121 |
|
Total shareholders’ equity |
|
23,887 |
|
|
|
23,617 |
|
Total liabilities and shareholders’ equity |
$ |
29,581 |
|
|
$ |
26,091 |
|
See accompanying notes to these Condensed Consolidated Financial Statements (Unaudited).
2
SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited)
(in thousands)
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Shares |
|
|
Amount |
|
|
Capital in Excess of Par |
|
|
Retained Earnings |
|
|
Total |
|
|||||
Balance, December 31, 2019 |
|
12,462 |
|
|
$ |
1,246 |
|
|
$ |
7,250 |
|
|
$ |
15,121 |
|
|
$ |
23,617 |
|
Stock-based compensation |
|
- |
|
|
|
- |
|
|
|
36 |
|
|
|
- |
|
|
|
36 |
|
Net income |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
277 |
|
|
|
277 |
|
Balance, March 31, 2020 |
|
12,462 |
|
|
$ |
1,246 |
|
|
$ |
7,286 |
|
|
$ |
15,398 |
|
|
$ |
23,930 |
|
Stock-based compensation |
|
- |
|
|
|
- |
|
|
|
35 |
|
|
|
- |
|
|
|
35 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(78 |
) |
|
|
(78 |
) |
Balance, June 30, 2020 |
|
12,462 |
|
|
$ |
1,246 |
|
|
$ |
7,321 |
|
|
$ |
15,320 |
|
|
$ |
23,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2018 |
|
12,408 |
|
|
$ |
1,241 |
|
|
$ |
7,063 |
|
|
$ |
15,778 |
|
|
$ |
24,082 |
|
Stock-based compensation |
|
- |
|
|
|
- |
|
|
|
42 |
|
|
|
- |
|
|
|
42 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(330 |
) |
|
|
(330 |
) |
Balance, March 31, 2019 |
|
12,408 |
|
|
$ |
1,241 |
|
|
$ |
7,105 |
|
|
$ |
15,448 |
|
|
$ |
23,794 |
|
Stock-based compensation |
|
- |
|
|
|
- |
|
|
|
42 |
|
|
|
- |
|
|
|
42 |
|
Stock options exercised |
|
51 |
|
|
|
5 |
|
|
|
36 |
|
|
|
- |
|
|
|
41 |
|
Net loss |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(716 |
) |
|
|
(716 |
) |
Balance, June 30, 2019 |
|
12,459 |
|
|
$ |
1,246 |
|
|
$ |
7,183 |
|
|
$ |
14,732 |
|
|
$ |
23,161 |
|
See accompanying notes to these Condensed Consolidated Financial Statements (Unaudited).
3
SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
|
Six Months Ended |
|
|||||
|
June 30, |
|
|||||
|
2020 |
|
|
2019 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
Net income (loss) |
$ |
199 |
|
|
$ |
(1,046 |
) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
522 |
|
|
|
369 |
|
Stock-based compensation |
|
71 |
|
|
|
84 |
|
Deferred income taxes |
|
65 |
|
|
|
(30 |
) |
Gain on sale of equipment |
|
- |
|
|
|
(110 |
) |
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
156 |
|
|
|
1,135 |
|
Inventories |
|
2,905 |
|
|
|
1,366 |
|
Prepaid expenses and other assets |
|
42 |
|
|
|
196 |
|
Income taxes receivable |
|
322 |
|
|
|
- |
|
Accounts payable, accrued expenses, and other liabilities |
|
296 |
|
|
|
(289 |
) |
Total adjustments to net income (loss) |
|
4,379 |
|
|
|
2,721 |
|
Net cash provided by operating activities |
|
4,578 |
|
|
|
1,675 |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
Purchase of property and equipment |
|
(17 |
) |
|
|
(101 |
) |
Proceeds from sale of property and equipment |
|
500 |
|
|
|
110 |
|
Cash paid for leasehold improvements |
|
(247 |
) |
|
|
- |
|
Reimbursement for leasehold improvements |
|
110 |
|
|
|
- |
|
Net cash provided by investing activities |
|
346 |
|
|
|
9 |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
Payments for debt issuance costs |
|
(141 |
) |
|
|
- |
|
Proceeds from exercise of stock options |
|
- |
|
|
|
41 |
|
Proceeds from PPP loan |
|
600 |
|
|
|
- |
|
Repayment of PPP loan |
|
(600 |
) |
|
|
- |
|
Net cash (used in) provided by financing activities |
|
(141 |
) |
|
|
41 |
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents |
|
4,783 |
|
|
|
1,725 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period |
|
1,094 |
|
|
|
6,232 |
|
Cash and cash equivalents, end of period |
$ |
5,877 |
|
|
$ |
7,957 |
|
See accompanying notes to these Condensed Consolidated Financial Statements (Unaudited).
4
SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements (Unaudited)
(in thousands, except per share data)
Note 1. |
Organization and Summary of Significant Accounting Policies |
(a) |
Company Background |
Scott’s Liquid Gold-Inc., a Colorado corporation was incorporated on February 15, 1954. Scott’s Liquid Gold-Inc. and its wholly-owned subsidiaries (collectively, the “Company,” “we,” “our,” or “us”) develop, market and sell quality household and personal care products. We are also a distributor in the United States of personal care products manufactured by another company. Our business is comprised of two segments: household products and personal care products.
(b) |
Principles of Consolidation |
Our Condensed Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.
(c) |
Basis of Presentation |
The unaudited Condensed Consolidated Statements of Operations, Condensed Consolidated Balance Sheets, and Condensed Consolidated Statements of Cash Flows included in this Report have been prepared by the Company. In our opinion, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at June 30, 2020 and results of operations and cash flows for all periods have been made.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These Condensed Consolidated Financial Statements should be read in conjunction with our financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019. The results of operations for the period ended June 30, 2020 are not necessarily indicative of the operating results for the full year.
(d) |
Use of Estimates |
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts in our financial statements of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include, but are not limited to, the realization of deferred tax assets, reserves for slow moving and obsolete inventory, customer returns and allowances, intangible asset useful lives and amortization method, fair value of assets acquired in business combinations, operating lease right-of-use assets and operating lease liabilities, and stock-based compensation. Actual results could differ from our estimates.
(e) |
Cash Equivalents |
We consider all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents.
(f)Inventories Valuation and Reserves
Inventories consist of raw materials and finished goods and are stated at the lower of cost (first-in, first-out method) or net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We estimate an inventory reserve, which is generally not material to our financial statements, for slow moving and obsolete products and raw materials based upon, among other things, an assessment of historical and anticipated sales of our products. In the event that actual results differ from our estimates, the results of future periods may be impacted.
5
Inventories were comprised of the following at:
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
Finished goods |
$ |
3,256 |
|
|
$ |
5,730 |
|
Raw materials |
|
1,757 |
|
|
|
2,218 |
|
Inventory reserve for obsolescence |
|
(77 |
) |
|
|
(107 |
) |
|
$ |
4,936 |
|
|
$ |
7,841 |
|
Our remaining raw materials balance is to be sold to contract manufacturing partners based on production demand.
(g) |
Property and Equipment |
Property and equipment are recorded at historical cost. Depreciation is provided using the straight-line method over the estimated useful lives of the assets ranging from three to 20 years. Production equipment and production support equipment are estimated to have useful lives of 15 to 20 years and three to 10 years, respectively. Office furniture and office machines are estimated to have useful lives of 10 to 20 years and three to five years, respectively. Maintenance and repairs are expensed as incurred. Improvements that extend the useful lives of the asset or provide improved efficiency are capitalized.
(h) |
Leases |
Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.
Certain nonlease components, such as maintenance and other services provided by the lessor, are included in the valuation of the lease. Leases with an initial term of 12 months or less, which are not material to our financial statements, are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. Lease agreements with lease and nonlease components are combined as a single lease component.
The Company evaluates reimbursable leasehold improvements based on whether improvements are indicative of a lessor or lessee asset. The Company concluded that all of its reimbursable leasehold improvement payments have qualified as lessor assets and, as such, have accounted for leasehold improvement payments as prepaid rent included in prepaid expenses on the condensed consolidated balance sheets.
(i) |
Intangible Assets and Goodwill |
Intangible assets consist of customer relationships, trade names, formulas, batching processes, internal-use software and a non-compete agreement. The fair value of the intangible assets is amortized over their estimated useful lives and range from a period of five to 25 years. Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired.
Internal-use software costs recognized as an intangible asset relates to capitalizable costs of computer software obtained for internal-use as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350-40-30-1. All other internal-use software costs are expensed as incurred by the Company. Amortization is recorded straight-line over the estimated useful life of the software once the software is ready for its intended use. As of June 30, 2020, our internal-use software was not ready for its intended use. The estimated useful life for internal-use software will be determined and periodically reassessed based on considerations for obsolescence, technology, competition, and other economic factors.
Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests, and in certain circumstances these assets are written down to fair value if impaired.
6
Financial instruments which potentially subject us to concentrations of credit risk include cash and cash equivalents and accounts receivable. We maintain our cash balances in the form of bank demand deposits with financial institutions that we believe are creditworthy. Historically, we have maintained balances in various operating accounts in excess of federally insured limits. We establish an allowance for doubtful accounts, which is generally not material to our financial statements, based upon factors surrounding the credit risk of specific customers, historical trends and other information. We have no significant financial instruments with off-balance sheet risk of accounting loss, such as foreign exchange contracts, option contracts or other foreign currency hedging arrangements.
The recorded amounts for cash and cash equivalents, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these financial instruments.
(k) |
Purchase Accounting for Acquisitions |
We apply the acquisition method of accounting for a business combination. In general, this methodology requires us to record assets acquired and liabilities assumed at their respective fair values at the date of acquisition. Any amount of the purchase price paid that is in excess of the estimated fair value of the net assets acquired is recorded as goodwill. For certain acquisitions, we also record a liability for contingent consideration based on estimated future business performance. We monitor our assumptions surrounding these estimated future cash flows and, if there is a significant change, would record an adjustment to the contingent consideration liability and a corresponding adjustment to either income or expense. We determine fair value using widely accepted valuation techniques, primarily discounted cash flow and market multiple analyses. These types of analyses require us to make assumptions and estimates regarding industry and economic factors, the profitability of future business strategies, discount rates and cash flow.
If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. If the contingent consideration paid for any of our acquisitions differs from the amount initially recorded, we would record either income or expense associated with the change in liability.
(l) |
Income Taxes |
Income taxes reflect the tax effects of transactions reported in the Condensed Consolidated Financial Statements and consist of taxes currently payable plus deferred income taxes related to certain income and expenses recognized in different periods for financial and income tax reporting purposes. Deferred income tax assets and liabilities are recognized for the future income tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases. A valuation allowance is established when it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which related temporary differences become deductible. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
Taxes are reported based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits or expense. We classify penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the Condensed Consolidated Statements of Income or accrued on the Condensed Consolidated Balance Sheets.
The effective tax rate for the six months ended June 30, 2020 and 2019 was (47.4%) and 2.4% respectively, which can differ from the statutory income tax rate due to permanent book-to-tax differences.
On March 27, 2020, President Trump signed into U.S. federal law the CARES Act, which is aimed at providing emergency assistance and health care for individuals, families, and businesses affected by the COVID-19 pandemic and generally supporting the U.S. economy. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. In particular, under the CARES Act, NOLs arising in 2018, 2019, and 2020 taxable years may be carried back to each of the preceding five years to generate a refund. The tax impact of the carryback of 2019 losses was recorded in the first quarter income tax provision. We are analyzing the different aspects of the CARES Act to determine whether any other provisions may impact us.
7
Our revenue recognition policy is significant because the amount and timing of revenue is a key component of our results of operations. Certain criteria are required to be met in order to recognize revenue. If these criteria are not met, then the associated revenue is deferred until it is met. When consideration is received in advance of the delivery of goods or services, a contract liability is recorded. Our revenue contracts are identified when purchase orders are received and accepted from customers and represent a single performance obligation to sell our products to a customer.
Net sales reflect the transaction prices for contracts, which include products shipped at selling list prices reduced by variable consideration. Variable consideration includes estimates for expected customer allowances, promotional programs for consumers, and sales returns. Based on our customer-by-customer history, our variable consideration estimates are generally accurate and subsequent adjustments are generally immaterial.
Variable consideration is primarily comprised of customer allowances. Customer allowances primarily include reserves for trade promotions to support price features, displays, slotting fees, and other merchandising of our products to our customers. Promotional programs for consumers primarily include coupons, rebates, and certain other promotional programs, and do not represent a significant portion of variable consideration. The costs of both customer allowances and promotional programs for consumers are estimated using either the expected value or most likely amount approach, depending on the nature of the allowance, using all reasonably available information, including our historical experience and current expectations. Customer allowances and promotional programs for consumers are reflected in the transaction price when sales are recorded. We may adjust our estimates based on actual results and consideration of other factors that cause allowances. In the event that actual results differ from our estimates, the results of future periods may be impacted.
Sales returns are generally not material to our financial statements, and do not comprise a significant portion of variable consideration. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce our revenue in that period.
Sales are recorded at the time that control of the products is transferred to customers. In evaluating the timing of the transfer of control of products to customers, we consider several indicators, including significant risks and rewards of products, our right to payment, and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to customers.
We have also established an allowance for doubtful accounts. We estimate this allowance based upon, among other things, an assessment of the credit risk of specific customers and historical trends. We believe our allowance for doubtful accounts is adequate to absorb any losses which may arise. In the event that actual losses differ from our estimates, the results of future periods may be impacted.
Customer allowances for trade promotions and allowance for doubtful accounts are included in net accounts receivable on the condensed consolidated balance sheets and were as follows at:
|
June 30, 2020 |
|
|
December 31, 2019 |
|
||
Trade promotions |
$ |
1,315 |
|
|
$ |
943 |
|
Allowance for doubtful accounts |
|
53 |
|
|
|
51 |
|
|
$ |
1,368 |
|
|
$ |
994 |
|
(n) |
Advertising Costs |
We expense advertising costs as incurred.
(o) |
Stock-Based Compensation |
We account for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of stock options with only service conditions using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the
8
components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the vesting period using the straight-line method, which approximates the service period.
The Company issued restricted stock unit ("RSUs") awards with restrictions that lapse upon the passage of time (service vesting) and satisfaction of market conditions targeted to our Company’s stock price. For those restricted stock unit awards with only service vesting, the Company recognizes compensation cost on a straight-line basis over the service period. For awards with both market and service conditions, the Company starts recognizing compensation cost over the requisite service period, with the effect of the market conditions reflected in the calculation of the award's fair value at grant date. The Company values awards with only service vesting requirements based on the grant date share price. The Company values awards with market and service conditions using a Monte Carlo simulation. The Company determines the requisite service period for awards with both market and service conditions based on the longer of the explicit service period and the derived service period. Stock awards that contain market vesting conditions are included in the computations of diluted EPS reflecting the average number of shares that would be issued based on the highest 30-day average market price during the reporting periods, if their effect is dilutive. If the condition is based on an average of market prices over some period of time, the corresponding average for the period is used.
(p) |
Operating Costs and Expenses Classification |
Cost of sales includes costs associated with manufacturing and distribution including labor, materials, freight-in, purchasing and receiving, quality control, repairs, maintenance, and other indirect costs, as well as warehousing and distribution costs. We classify freight-out as selling expenses. Other selling expenses consist primarily of costs for sales and sales support personnel, brokerage commissions, and promotional costs. Freight-out costs included in selling expenses totaled $619 and $555 for the three months ended June 30, 2020 and 2019, respectively, and totaled $1,306 and $1,221 for the six months ended June 30, 2020 and 2019, respectively.
General and administrative expenses consist primarily of wages and benefits associated with management and administrative support departments, business insurance costs, professional fees, office facility related expenses, and other general support costs.
(q) |
Recently Issued Accounting Standards |
In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The new guidance simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. For public companies, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, with early adoption permitted. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. ASU 2019-12 is not expected to have a material impact on our financial statements.
In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The purpose of ASU 2020-04 is to provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. This guidance primarily provides temporary optional expedients which simplify the accounting for contract modifications to existing debt agreements expected to arise from the market transition from LIBOR to alternative reference rates. The amendments in ASU 2020-04 are effective for all entities as of March 12, 2020 through December 31, 2022. The optional expedients were available to be used upon issuance of this guidance but we have not yet applied the guidance because we have not yet modified any of our existing contracts for reference rate reform. The Company is currently assessing the impact of ASU 2020-04 on our Condensed Consolidated Financial Statements.
(r) |
Recently Adopted Accounting Standards |
In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments —Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This guidance, as amended by subsequent ASUs on the topic, requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This guidance was effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments—Credit Losses. ASU 2019-11 required entities that did not adopt the amendments in ASU 2016-13 as of November 2019 to adopt ASU 2019-11. This ASU contains the same effective dates and transition requirements
9
as ASU 2016-13. We adopted ASU 2016-13 and ASU 2019-11 effective January 1, 2020. The Company determined the standards did not have a material impact on our condensed consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). The new guidance modified disclosure requirements related to fair value measurement. The amendments in ASU 2018-13 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Effective January 1, 2020, the Company adopted ASU 2018-13 and concluded the standard did not have a material impact on our condensed consolidated financial statements.
Note 2. |
Stock-Based Compensation |
During the six months ended June 30, 2020, we did not grant any options to acquire shares of our common stock or any restricted stock units. No restricted stock units vested during the six months ended June 30, 2020.
Compensation cost related to stock options totaled $40 and $84 in the six months ended June 30, 2020 and 2019, respectively. Approximately $133 of total unrecognized compensation costs related to non-vested stock options is expected to be recognized over the next two years, depending on the vesting provisions of the options. There was no tax benefit from recording the non-cash expense as it relates to the options granted to employees, as these were qualified stock options which are not normally tax deductible.
Compensation cost related to RSUs totaled $31 for the six months ended June 30, 2020. Approximately $145 of total unrecognized compensation costs related to non-vested RSUs is expected to be recognized ratably until on or around November 14, 2022.
Note 3. |
Earnings per Share |
Per share data is determined by using the weighted average number of common shares outstanding. Common equivalent shares are considered only for diluted earnings per share, unless considered anti-dilutive. Common equivalent shares, determined using the treasury stock method, result from stock options with exercise prices that are below the average market price of the common stock.
Basic earnings per share include no dilution and are computed by dividing income available to common shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential of securities that could share in our earnings.
A reconciliation of the weighted average number of common shares outstanding (in thousands) is as follows. The dilutive effect of stock options and RSUs are excluded for periods in which the Company has a net loss because the impact is anti-dilutive.
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
||||
Common shares outstanding, beginning of the period |
|
12,462 |
|
|
|
12,408 |
|
|
|
12,462 |
|
|
|
12,408 |
|
Weighted average common shares issued |
|
- |
|
|
|
28 |
|
|
|
- |
|
|
|
14 |
|
Weighted average number of common shares outstanding |
|
12,462 |
|
|
|
12,436 |
|
|
|
12,462 |
|
|
|
12,422 |
|
Dilutive effect of common share equivalents |
|
- |
|
|
|
- |
|
|
|
109 |
|
|
|
- |
|
Diluted weighted average number of common shares outstanding |
|
12,462 |
|
|
|
12,436 |
|
|
|
12,571 |
|
|
|
12,422 |
|
Common stock equivalents (in thousands) that have been excluded from the calculation of earnings per share because they would have been anti-dilutive:
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
||||
Stock options |
|
258 |
|
|
|
693 |
|
|
|
258 |
|
|
|
693 |
|
10
Note 4. |
Segment Information |
We operate in two different segments: household products and personal care products. We have chosen to organize our business around these segments based on differences in the products sold. Accounting policies for our segments are the same as those described in Note 1. We evaluate segment performance based on segment income or loss from operations.
The following provides information on our segments for the three and six months ended June 30:
|
Three Months Ended June 30, 2020 |
|
|||||||||
|
Household Products |
|
|
Personal Care Products |
|
|
Total |
|
|||
Net sales |
$ |
2,272 |
|
|
$ |
3,811 |
|
|
$ |
6,083 |
|
Income (loss) from operations |
|
202 |
|
|
|
(592 |
) |
|
|
(390 |
) |
Depreciation and amortization |
|
137 |
|
|
|
156 |
|
|
|
293 |
|
|
Three Months Ended June 30, 2019 |
|
|||||||||
|
Household Products |
|
|
Personal Care Products |
|
|
Total |
|
|||
Net sales |
$ |
1,233 |
|
|
$ |
5,149 |
|
|
$ |
6,382 |
|
Income (loss) from operations |
|
15 |
|
|
|
(789 |
) |
|
|
(774 |
) |
Depreciation and amortization |
|
20 |
|
|
|
163 |
|
|
|
183 |
|
|
Six Months Ended June 30, 2020 |
|
|||||||||
|
Household Products |
|
|
Personal Care Products |
|
|
Total |
|
|||
Net sales |
$ |
4,404 |
|
|
$ |
9,533 |
|
|
$ |
13,937 |
|
Income (loss) from operations |
|
253 |
|
|
|
(393 |
) |
|
|
(140 |
) |
Capital and intangible asset expenditures |
|
17 |
|
|
|
- |
|
|
|
17 |
|
Depreciation and amortization |
|
209 |
|
|
|
313 |
|
|
|
522 |
|
|
Six Months Ended June 30, 2019 |
|
|||||||||
|
Household Products |
|
|
Personal Care Products |
|
|
Total |
|
|||
Net sales |
$ |
2,437 |
|
|
$ |
10,750 |
|
|
$ |
13,187 |
|
Loss from operations |
|
(155 |
) |
|
|
(1,079 |
) |
|
|
(1,234 |
) |
Capital and intangible asset expenditures |
|
101 |
|
|
|
- |
|
|
|
101 |
|
Depreciation and amortization |
|
42 |
|
|
|
327 |
|
|
|
369 |
|
Note 5. |
Acquisition |
On October 1, 2019, we entered into an Asset Purchase Agreement (the “Paramount Purchase Agreement”) with Paramount Chemical Specialties, Inc. (“Paramount”). Pursuant to the Purchase Agreement, we purchased all of Paramount’s intangible assets, finished goods inventory, and assets used in connection with the manufacture, sale and distribution of the Kids N Pets® and Messy Pet® brands (collectively, the “ Paramount Acquisition”). The Company concluded that the Paramount Acquisition qualified as a business combination under ASC 805.
The total consideration paid for the Paramount Acquisition was $5,583 and included contingent consideration we valued at $27.
11
The following summarizes the aggregate fair values of the assets acquired during 2019 as of the date of the Paramount Acquisition:
Inventories |
$ |
306 |
|
Intangible assets |
|
3,595 |
|
Goodwill |
|
1,709 |
|
Total assets acquired |
$ |
5,610 |
|
Intangible assets in the table above consist of the following:
|
Intangible Assets |
|
|
Useful Life |
|
||
Customer relationships |
$ |
2,330 |
|
|
|
10 to 13 years |
|
Trade names |
|
880 |
|
|
|
10 to 25 years |
|
Formulas and batching processes |
|
370 |
|
|
|
10 years |
|
Non-compete |
|
15 |
|
|
|
5 years |
|
|
$ |
3,595 |
|
|
|
|
|
In addition to the assets described above, the Company recorded a $27 liability associated with the contingent consideration, which is presented in other liabilities on the consolidated balance sheets.
The estimates of the fair value of the assets acquired assumed at the date of the Paramount Acquisition are subject to adjustment during the measurement period (up to one year from the Paramount Acquisition date). The primary areas of the accounting for the Paramount Acquisition that are not yet finalized relate to the fair value of intangible assets acquired, residual goodwill and any related tax impact. The fair value of these net assets acquired are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. While the Company believes that such preliminary estimates provide a reasonable basis for estimating the fair value of assets acquired, it evaluates any necessary information prior to finalization of the fair value. During the measurement period, the Company will adjust assets if new information is obtained about facts and circumstances that existed as of the Paramount Acquisition date that, if known, would have resulted in the revised estimated values of those assets as of that date. The impact of all changes that do not qualify as measurement period adjustments are included in current period earnings. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the condensed consolidated financial statements could be subject to a possible impairment of the intangible assets or goodwill, or require acceleration of the amortization expense of intangible assets in subsequent periods.
The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the three and six months ended June 30, 2019, as if the Paramount Acquisition had been completed on January 1, 2019.
|
Three Months Ended June 30, 2019 |
|
|
Six Months Ended June 30, 2019 |
|
||
Net sales |
$ |
7,177 |
|
|
$ |
15,526 |
|
Net (loss) income |
|
(617 |
) |
|
|
(848 |
) |
This selected unaudited pro forma condensed consolidated financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would have been if the Paramount Acquisition had been completed on that date. Moreover, this information does not indicate what our future operating results will be. The information for 2019 prior to the Paramount Acquisition is based on prior accounting records maintained by Paramount. In some cases, Paramount’s accounting policies may differ materially from accounting policies adopted by the Company following the Paramount Acquisition.
The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the Paramount Acquisition to reflect: (1) the additional amortization that would have been charged to the acquired intangible assets; (2) additional interest expense relating to the borrowings on the our line of credit; and (3) the tax impacts.
12
Goodwill and intangible assets, which are related to our acquisition of our Prell®, Denorex®, and Kids N Pets® brands, consisted of the following:
|
As of June 30, 2020 |
|
|
As of December 31, 2019 |
|
||||||||||||||||||
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
Net Carrying Value |
|
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
Net Carrying Value |
|
||||||
Intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer relationships |
$ |
6,352 |
|
|
$ |
1,751 |
|
|
$ |
4,601 |
|
|
$ |
6,352 |
|
|
$ |
1,455 |
|
|
$ |
4,897 |
|
Trade names |
|
3,242 |
|
|
|
664 |
|
|
|
2,578 |
|
|
|
3,242 |
|
|
|
563 |
|
|
|
2,679 |
|
Formulas and batching processes |
|
1,039 |
|
|
|
251 |
|
|
|
788 |
|
|
|
1,039 |
|
|
|
204 |
|
|
|
835 |
|
Internal-use software (not placed in service) |
|
286 |
|
|
|
- |
|
|
|
286 |
|
|
|
286 |
|
|
|
- |
|
|
|
286 |
|
Non-compete agreement |
|
41 |
|
|
|
23 |
|
|
|
18 |
|
|
|
41 |
|
|
|
19 |
|
|
|
22 |
|
|
|
10,960 |
|
|
|
2,689 |
|
|
|
8,271 |
|
|
|
10,960 |
|
|
|
2,241 |
|
|
|
8,719 |
|
Goodwill |
|
|
|
|
|
|
|
|
|
3,230 |
|
|
|
|
|
|
|
|
|
|
|
3,230 |
|
Total intangible assets |
|
|
|
|
|
|
|
|
$ |
11,501 |
|
|
|
|
|
|
|
|
|
|
$ |
11,949 |
|
Amortization expense for the three months ended June 30, 2020 and 2019 was $224 and $155, respectively. Amortization expense for the six months ended June 30, 2020 and 2019 was $448 and $310, respectively.
Estimated amortization expense for 2020 and subsequent years is as follows:
2020 (remaining) |
$ |
447 |
|
2021 |
|
893 |
|
2022 |
|
891 |
|
2023 |
|
891 |
|
2024 |
|
890 |
|
Thereafter |
|
3,973 |
|
Total |
$ |
7,985 |
|
Note 7. |
Long-Term Debt and Line-of-Credit |
We had a revolving credit facility (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. (“Chase”) for $4,000, with interest of (i) the LIBO Rate + 2.25%; or (ii) the Prime Rate, with a floor of the one month LIBO Rate + 2.25%, and a termination date of June 30, 2021 or any earlier date on which the revolving commitment was otherwise terminated pursuant to the Credit Agreement. Under the Credit Agreement we were obligated to pay quarterly an unused commitment fee equal to 0.25% per annum on the daily amount of the undrawn portion of the revolving line-of-credit. The revolving credit facility is collateralized by all of the assets of the Company.
The Credit Agreement subjected the Company to affirmative, negative, and financial covenants on a quarterly basis. The Company was in compliance with the Credit Agreement as of June 30, 2020 and with covenants in the Credit Agreement as of December 31, 2019, respectively. We did not have any debt outstanding as of June 30, 2020 and December 31, 2019.
On July 1, 2020, we entered into a new debt agreement with UMB Bank, N.A. (“UMB”) and terminated our Credit Agreement with Chase. Please see Note 10 for more detail regarding the transaction. Due to our debt agreement with UMB, the termination of our Credit Agreement with Chase, and the timing of covenant requirements under the Credit Agreement, we did not have required covenants as of June 30, 2020.
Note 8. |
Leases |
We have entered into leases for our corporate headquarters and office equipment with remaining lease terms up to 11 years. Some of these leases include both lease and nonlease components, which are accounted for as a single lease component as we have elected the practical expedient to combine these components for all leases. As most of the leases do not provide an implicit rate, we calculated the right-of-use assets and lease liabilities using our secured incremental borrowing rate at the lease commencement date. We currently do not have any finance leases outstanding.
13
Effective March 10, 2020, we consummated our agreement with Elevation Labs (“Elevation”), wherein we were relieved of our warehouse leases on the effective date. Effective March 30, 2020, we assigned our office lease to Elevation who then subleased a portion of the office space to us through June 30, 2020 to allow us time to transition to our new corporate offices.
On March 11, 2020, we executed an office lease for a new corporate headquarters. As of that date, we had the right to control the use of the asset, which qualified as an operating lease. There were no initial direct costs associated with our new office lease and our deposit is fully refundable.
Information related to leases was as follows:
Three Months Ended |
|
Six Months Ended |
|
Operating lease information: |
|
|
|
Operating lease cost |
$ 105 |
|
$ 145 |
Operating cash flows from operating leases |
7 |
|
14 |
Net assets obtained in exchange for new operating lease liabilities |
- |
|
3,156 |
|
|
|
|
Weighted average remaining lease term in years |
10.33 |
|
10.33 |
Weighted average discount rate |
5.1% |
|
5.1% |
Future minimum annual lease payments are as follows:
2020 (remaining) |
$ |
46 |
|
2021 |
|
411 |
|
2022 |
|
399 |
|
2023 |
|
413 |
|
2024 |
|
420 |
|
Thereafter |
|
2,586 |
|
Total minimum lease payments |
$ |
4,275 |
|
Less imputed interest |
|
(1,032 |
) |
|
|
|
|
Total operating lease liability |
$ |
3,243 |
|
Note 9. |
Income from Distribution Agreement Termination |
On May 8, 2020, we entered into a settlement agreement with Montagne Jeunesse (“MJ”), the manufacturer of 7th Heaven skin care sachets, wherein both parties agreed to terminate our exclusive distribution agreement (the “Termination Agreement”). During the three months ended June 30, 2020, we received two transition payments totaling $350, which is included in other income on the condensed consolidated statements of operations. Further, $1.0 million of inventory was repurchased by MJ during the three months ended June 30, 2020.
Note 10. |
Subsequent Events |
On June 25, 2020, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with CR Brands, Inc., a Delaware corporation (“CR Brands”), and Sweep Acquisition Company, a Delaware corporation (“Sweep” and together with CR Brands, “Sellers”), pursuant to which we agreed to purchase from Sellers substantially all of the assets, properties, rights and interests of Sellers primarily used in the business of designing, formulating, marketing and selling laundry care products to retail and wholesale customers under the Biz® and Dryel® brand names (the “Business”). The transactions contemplated by the Purchase Agreement were consummated on July 1, 2020 (the “CR Brands Acquisition”). The total consideration SLG Chemicals paid for the Business was $9,250, plus an amount equal to the value of the Business-related inventory (including raw materials, work-in-progress inventory, finished goods and bill of material expense items) as of the closing, up to a maximum of $1,700, plus an earnout that will be paid following the second anniversary of the closing, the amount of which is based on sales to a certain new customer.
On July 1, 2020, we also entered into a Loan and Security Agreement (the “Loan Agreement”) with UMB, as lender, pursuant to which UMB provided a term loan and a revolving credit facility that was used to finance a portion of the CR Brands Acquisition and to repay amounts owed under, and terminate, the Credit Agreement and will be used for working capital in the future. The term loan amount is $3,000 with monthly payments fully amortized over three years and interest at the LIBOR Rate + 4.5%, with
14
a floor of 5.5%. The revolving credit facility amount is up to $7,000 with interest at the LIBOR Rate + 3.75%, with a floor of 4.75%. The revolving credit facility will terminate on July 1, 2023 or any earlier date on which the revolving commitment is otherwise terminated pursuant to the Loan Agreement. The loans are secured by all of the assets of the Company and all of its subsidiaries.
On July 1, 2020, we used $3,000 of term debt and drew $3,006 from the UMB revolving credit facility to fund the CR Brands Acquisition.
15
Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2019. This Item 2 contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those made, projected or implied in the forward-looking statements. Please refer to "Item 1A. Risk Factors" in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of the uncertainties, risks and assumptions associated with these statements.
Executive Overview
Our Business
Scott’s Liquid Gold-Inc. exists to positively impact consumers’ lives in the markets we serve while creating shareholder value. We develop, market, and sell high-quality, high-value household and personal care products nationally and internationally to mass merchandisers, drugstores, supermarkets, hardware stores, e-commerce retailers, other retail outlets, and to wholesale distributors.
COVID-19 Pandemic
During the first quarter of 2020, the global economy began experiencing a downturn related to the impacts of the COVID-19 global pandemic. Such impacts have included significant volatility in the global stock markets, a 150-basis-point reduction in the target federal funds rate, the enactment of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, including the Payroll Protection Program administered by the Small Business Administration, and a variety of local, state and federal restrictions, measures and guidance. While many businesses resumed operations towards the end of the second quarter of 2020, the number of COVID-19 cases continues to increase and the duration of the impact still remains uncertain. We expect to see continued volatility in the economic markets and government responses to the COVID-19 pandemic. These changing conditions and governmental responses could have impacts on our balance sheet and statement of operations for the remainder of the year or longer.
Health and Safety
We have taken proactive, aggressive action to protect the health and safety of our employees, customers, partners and other counterparties. We have implored employees to continue to work from home and have strict requirements for employees who must enter our corporate office, such as body temperature documentation, mask requirements, and scheduling that limits physical employee interaction. We have continued our travel suspension and workspace disinfection. We expect to continue to implement these and other measures as appropriate.
Customer Demand
At the onset of the pandemic, as a result of government-mandated stay-at-home orders, some of our customers were impacted and forced to cease operations. Customer closings primarily impacted revenue for our Batiste Dry Shampoo distributed products during the last part of March 2020. Shipments to our major Batiste Dry Shampoo customers resumed in May 2020, but at lower levels than preceded the epidemic. Any other customer closures or restrictions would negatively impact our business.
Liquidity
Although there is uncertainty related to the anticipated impact of the recent COVID-19 outbreak on our future results, we believe our business model, our current cash reserves, available COVID-19 relief programs and our new debt agreement with UMB leave us well-positioned to manage our business through this crisis as it continues to develop and will be sufficient to meet our operational cash needs during the next twelve months. Certain of our customers previously delayed payment as a result of the outbreak, but those customers resumed regular payment terms during the second quarter of 2020.
Supply Chain and Outsourcing Partners
As a result of COVID-19, we have encountered various supply chain disruptions impacting the availability of inputs for our finished goods products. We have been proactively identifying alternative sources for delayed raw materials and our highest demand products remain unaffected. All of our outsourcing partners, including contract manufacturing plants and third-party logistics warehouses, have remained open during the entirety of COVID-19.
16
We continue to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. Given the dynamic nature of this situation, we cannot reasonably estimate the impacts of COVID-19 on our financial condition, results of operations or cash flows in the future. In addition, see Part II—Item 1A, “Risk Factors,” included herein for updates to our risk factors regarding risks associated with the COVID-19 pandemic.
Results of Operations
Three months ended June 30, 2020 compared to three months ended June 30, 2019
|
Three Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Net sales |
$ |
6,083 |
|
|
$ |
6,382 |
|
|
$ |
(299 |
) |
|
|
(4.7 |
%) |
Cost of sales |
|
3,215 |
|
|
|
4,442 |
|
|
|
(1,227 |
) |
|
|
(27.6 |
%) |
Gross profit |
|
2,868 |
|
|
|
1,940 |
|
|
|
928 |
|
|
|
47.8 |
% |
Gross margin |
|
47.1 |
% |
|
|
30.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising |
|
141 |
|
|
|
202 |
|
|
|
(61 |
) |
|
|
(30.2 |
%) |
Selling |
|
1,614 |
|
|
|
1,354 |
|
|
|
260 |
|
|
|
19.2 |
% |
General and administrative |
|
1,503 |
|
|
|
1,158 |
|
|
|
345 |
|
|
|
29.8 |
% |
Total operating expenses |
|
3,258 |
|
|
|
2,714 |
|
|
|
544 |
|
|
|
20.0 |
% |
Loss from operations |
|
(390 |
) |
|
|
(774 |
) |
|
|
384 |
|
|
|
49.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
2 |
|
|
|
30 |
|
|
|
(28 |
) |
|
|
(93.3 |
%) |
Interest expense |
|
(74 |
) |
|
|
(4 |
) |
|
|
(70 |
) |
|
|
(1,750.0 |
%) |
Gain on sale of equipment |
|
- |
|
|
|
110 |
|
|
|
(110 |
) |
|
|
(100.0 |
%) |
Other income |
|
350 |
|
|
|
- |
|
|
|
350 |
|
|
|
100.0 |
% |
Loss before income taxes |
|
(112 |
) |
|
|
(638 |
) |
|
|
526 |
|
|
|
82.4 |
% |
Income tax benefit (expense) |
|
34 |
|
|
|
(78 |
) |
|
|
112 |
|
|
|
143.6 |
% |
Net loss |
$ |
(78 |
) |
|
$ |
(716 |
) |
|
$ |
638 |
|
|
|
89.1 |
% |
Decrease in net loss primarily due to the following:
|
• |
Increase in gross profit primarily attributable to the introduction of our Kids N Pets and SLG One products during the fourth quarter of 2019, a margin increase for our Denorex products due to its production outsourcing, and lower costs associated with certain of our brands for which manufacturing was outsourced during the second quarter of 2020. |
|
• |
Other income associated with the termination of our exclusive distribution agreement with MJ. |
|
• |
Income tax benefit during the three months ended June 30, 2020. |
|
• |
The decrease in net loss was partially offset by: |
|
o |
Decrease in Batiste Dry Shampoo sales due to customer closures and a decrease in 7th Heaven skin care sachet sales due to the termination of our exclusive distribution agreement with MJ. |
|
o |
$300 of costs and expenses associated with our manufacturing and logistics transition and professional services associated with our recent acquisition. |
|
o |
Gain on sale of equipment during 2019. |
17
Household Products
The following table shows comparative net sales, gross margin, gross profit, income from operations, volume and percentage changes for household products between periods:
|
Three Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Net sales |
$ |
2,272 |
|
|
$ |
1,233 |
|
|
$ |
1,039 |
|
|
|
84.3 |
% |
Gross profit |
$ |
1,338 |
|
|
$ |
572 |
|
|
$ |
766 |
|
|
|
133.9 |
% |
Gross margin |
|
58.9 |
% |
|
|
46.4 |
% |
|
|
|
|
|
|
|
|
Income from operations |
$ |
202 |
|
|
$ |
15 |
|
|
$ |
187 |
|
|
|
1,246.7 |
% |
|
• |
Household products increase in net sales and income from operations was primarily attributable to our Kids N Pets acquisition and the introduction of our new SLG One product, both of which drove higher margins for our household products segment. |
Personal Care Products
The following table shows comparative net sales, gross margin, gross profit, loss from operations, volume and percentage changes for personal care products between periods:
|
Three Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Personal care net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales - distributed products |
$ |
1,216 |
|
|
$ |
2,474 |
|
|
$ |
(1,258 |
) |
|
|
(50.8 |
%) |
Net sales - manufactured products |
|
2,595 |
|
|
|
2,675 |
|
|
|
(80 |
) |
|
|
(3.0 |
%) |
Total personal care net sales |
$ |
3,811 |
|
|
$ |
5,149 |
|
|
$ |
(1,338 |
) |
|
|
(26.0 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
$ |
1,530 |
|
|
$ |
1,368 |
|
|
$ |
162 |
|
|
|
11.8 |
% |
Gross margin |
|
40.1 |
% |
|
|
26.6 |
% |
|
|
|
|
|
|
|
|
Loss from operations |
$ |
(592 |
) |
|
$ |
(789 |
) |
|
$ |
197 |
|
|
|
25.0 |
% |
|
• |
Net sales of distributed personal care products decreased primarily due to lower Batiste sales as a result of COVID-19 customer closures and the termination of our exclusive distribution agreement with MJ. |
|
• |
Net sales of manufactured personal care products decreased primarily due to lower sales of Denorex as a result of supply chain issues for sourcing certain raw materials, which was caused by the COVID-19 pandemic. |
|
• |
Decrease in loss from operations was attributable to increased gross margin as a percentage of net sales, which was primarily the result of initial increased margins for our Prell and Denorex brands driven by decreased costs of goods from outsourcing in the second quarter of 2020 and the middle of 2019, respectively. |
18
Six months ended June 30, 2020 compared to six months ended June 30, 2019
|
Six Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Net sales |
$ |
13,937 |
|
|
$ |
13,187 |
|
|
$ |
750 |
|
|
|
5.7 |
% |
Cost of sales |
|
7,605 |
|
|
|
8,642 |
|
|
|
(1,037 |
) |
|
|
(12.0 |
%) |
Gross profit |
|
6,332 |
|
|
|
4,545 |
|
|
|
1,787 |
|
|
|
39.3 |
% |
Gross margin |
|
45.4 |
% |
|
|
34.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising |
|
362 |
|
|
|
386 |
|
|
|
(24 |
) |
|
|
(6.2 |
%) |
Selling |
|
3,203 |
|
|
|
3,012 |
|
|
|
191 |
|
|
|
6.3 |
% |
General and administrative |
|
2,907 |
|
|
|
2,381 |
|
|
|
526 |
|
|
|
22.1 |
% |
Total operating expenses |
|
6,472 |
|
|
|
5,779 |
|
|
|
693 |
|
|
|
12.0 |
% |
Loss from operations |
|
(140 |
) |
|
|
(1,234 |
) |
|
|
1,094 |
|
|
|
88.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
3 |
|
|
|
61 |
|
|
|
(58 |
) |
|
|
(95.1 |
%) |
Interest expense |
|
(78 |
) |
|
|
(9 |
) |
|
|
(69 |
) |
|
|
(766.7 |
%) |
Gain on sale of equipment |
|
- |
|
|
|
110 |
|
|
|
(110 |
) |
|
|
(100.0 |
%) |
Other income |
|
350 |
|
|
|
- |
|
|
|
350 |
|
|
|
100.0 |
% |
Income (loss) before income taxes |
|
135 |
|
|
|
(1,072 |
) |
|
|
1,207 |
|
|
|
112.6 |
% |
Income tax benefit |
|
64 |
|
|
|
26 |
|
|
|
38 |
|
|
|
146.2 |
% |
Net income (loss) |
$ |
199 |
|
|
$ |
(1,046 |
) |
|
$ |
1,245 |
|
|
|
119.0 |
% |
Change in net income (loss) primarily due to the following:
|
• |
Increase in gross profit primarily attributable to the introduction of our Kids N Pets and SLG One products during the fourth quarter of 2019, a margin increase for our Denorex products due to outsourcing during the middle of 2019, and lower costs associated with certain of our brands for which manufacturing was outsourced during the second quarter of 2020. |
|
• |
Other income associated with the termination of our exclusive distribution agreement with MJ. |
|
• |
Increase in income tax benefit. |
|
• |
The change in net income (loss) was partially offset by: |
|
o |
$465 of costs and expenses associated with our manufacturing and logistics transition, as well as staffing for and professional services associated with our recent acquisition. |
|
o |
Gain on sale of equipment during 2019. |
Segment Results
Household Products
The following table shows comparative net sales, gross margin, gross profit, income (loss) from operations, volume and percentage changes for household products between periods:
|
Six Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Net sales |
$ |
4,404 |
|
|
$ |
2,437 |
|
|
$ |
1,967 |
|
|
|
80.7 |
% |
Gross profit |
$ |
2,427 |
|
|
$ |
1,108 |
|
|
$ |
1,319 |
|
|
|
119.0 |
% |
Gross margin |
|
55.1 |
% |
|
|
45.5 |
% |
|
|
|
|
|
|
|
|
Income (loss) from operations |
$ |
253 |
|
|
$ |
(155 |
) |
|
$ |
408 |
|
|
|
263.2 |
% |
19
Personal Care Products
The following table shows comparative net sales, gross margin, gross profit, income (loss) from operations, volume and percentage changes for personal care products between periods:
|
Six Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Personal care net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributed products |
$ |
4,121 |
|
|
$ |
4,811 |
|
|
$ |
(690 |
) |
|
|
(14.3 |
%) |
Manufactured products |
|
5,412 |
|
|
|
5,939 |
|
|
|
(527 |
) |
|
|
(8.9 |
%) |
Total personal care net sales |
$ |
9,533 |
|
|
$ |
10,750 |
|
|
$ |
(1,217 |
) |
|
|
(11.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
$ |
3,905 |
|
|
$ |
3,437 |
|
|
$ |
468 |
|
|
|
13.6 |
% |
Gross margin |
|
41.0 |
% |
|
|
32.0 |
% |
|
|
|
|
|
|
|
|
Loss from operations |
$ |
(393 |
) |
|
$ |
(1,079 |
) |
|
$ |
686 |
|
|
|
63.6 |
% |
|
• |
Net sales of distributed personal care products decreased primarily due to lower Batiste sales during the second quarter of 2020, as a result of COVID-19 customer closures, and the termination of our exclusive distribution agreement with MJ. |
|
• |
Net sales of manufactured personal care products decreased primarily due to lower sales to China of Alpha® Skin Care and lower sales of Denorex as a result of supply chain issues for sourcing certain raw materials during the second quarter of 2020, which was caused by the COVID-19 pandemic. |
|
• |
Decrease in loss from operations was attributable to increased gross margin as a percentage of net sales, which was primarily the result of increased margins for our Prell and Denorex brands driven by decreased costs of goods from outsourcing in the second quarter of 2020 and the middle of 2019, respectively. |
Liquidity and Capital Resources
Financing Agreements
Please see Note 7 to our Condensed Consolidated Financial Statements for information on our Credit Agreement with Chase and Note 10 to our Condensed Consolidated Financial Statements for detail regarding our new Loan Agreement with UMB, which replaced our Credit Agreement with Chase on July 1, 2020.
Liquidity and Changes in Cash Flows
At June 30, 2020, we had our maximum commitment of $4,000 available and unused on our revolving credit facility with Chase, and approximately $5,877 in cash on hand, an increase of $4,783 when compared to the balance as of December 31, 2019. On July 1, 2020, we terminated our revolving credit facility with Chase and entered into the Loan Agreement with UMB, under which we will have a maximum commitment of $3,000 under a term loan and a $7,000 maximum revolving commitment, the availability of which is dependent upon our accounts receivable and inventory balances. On July 1, 2020, we used $3,000 of term debt and drew $3,006 from the UMB revolving credit facility to fund the CR Brands Acquisition.
20
The following is a summary of cash provided by or (used in) each of the indicated types of activities:
|
Six Months Ended June 30, (in thousands) |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
Increase / (Decrease) |
|
|||||
|
2020 |
|
|
2019 |
|
|
$ |
|
|
% |
|
||||
Operating activities |
$ |
4,578 |
|
|
$ |
1,675 |
|
|
$ |
2,903 |
|
|
|
173.3 |
% |
Investing activities |
|
346 |
|
|
|
9 |
|
|
|
337 |
|
|
|
3,744.4 |
% |
Financing activities |
|
(141 |
) |
|
|
41 |
|
|
|
(182 |
) |
|
|
(443.9 |
%) |
|
• |
Net cash from operating activities was primarily the result of reducing a large finished goods inventory balance we built heading into our outsourcing of manufacturing and logistics, selling back $1,000 of inventory to MJ in conjunction with the termination agreement, and improved profit margins associated with new and outsourced products. |
|
• |
Net cash from investing activities was related to our sale of fixed assets to Elevation Labs on March 10, 2020 and proceeds from the termination of our exclusive MJ distribution agreement, which were partially offset by reimbursable payments for leasehold improvements associated with our new corporate headquarters. |
|
• |
Net cash used in financing activities for deferred financing costs related to our new Loan Agreement. |
We anticipate that our existing cash and our anticipated future cash flow from operations, together with our Loan Agreement, will be sufficient to meet our cash requirements for the 12 months following the filing date of this Report. During 2020, we expect to incur additional capital expenditures associated with our ERP system implementation beginning at the end of 2020. These capital expenditures are fixed and recurring monthly payments for implementation services and we have already paid for our ERP software.
Subsequent Events
On June 25, 2020, we entered into the Purchase Agreement with CR Brands and Sweep, pursuant to which we agreed to purchase from Sellers substantially all of the assets, properties, rights and interests of Sellers primarily used in the business of designing, formulating, marketing and selling laundry care products to retail and wholesale customers under the Biz® and Dryel® brand names. The transactions contemplated by the Purchase Agreement were consummated on July 1, 2020. The total consideration we paid for the Business was $9,250, plus an amount equal to the value of the Business-related inventory (including raw materials, work-in-progress inventory, finished goods and bill of material expense items) as of the closing, up to a maximum of $1,700, plus an earnout that will be paid following the second anniversary of the closing, the amount of which is based on sales to a certain new customer.
On July 1, 2020, we entered into a Loan Agreement with UMB, as lender, pursuant to which UMB provided a term loan and a revolving credit facility that was used to finance a portion of the Acquisition and to repay amounts owed under, and terminate, our Credit Agreement with Chase and will be used for working capital in the future. The term loan amount is $3,000 with monthly payments fully amortized over three years and interest at the LIBOR Rate + 4.5%, with a floor of 5.5%. The revolving credit facility amount is up to $7,000 with interest at the LIBOR Rate + 3.75%, with a floor of 4.75%. The revolving credit facility will terminate on July 1, 2023 or any earlier date on which the revolving commitment is otherwise terminated pursuant to the Loan Agreement. The loans are secured by all of the assets of the Company and all of its subsidiaries.
On July 1, 2020, we used $3,000 of term debt and drew $3,006 from the UMB revolving credit facility to fund the CR Brands Acquisition.
21
Not applicable.
Disclosure Controls and Procedures
As of June 30, 2020, we conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of June 30, 2020.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting during the six months ended June 30, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
22
In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and subsequent quarterly reports on Form 10-Q, which could materially affect our business, financial condition or future results.
Disruptions in our supply chain and other factors affecting the distribution of our finished goods inventory could adversely impact our business.
A disruption within our logistics or supply chain network could adversely affect our ability to maintain appropriate inventory or deliver products in a timely manner, which could impair our ability to meet customer demand for products and result in lost sales, increased supply chain costs, or damage to our reputation. As a result of COVID-19, we have encountered shortages of raw materials for certain of our products, which has prevented us from meeting certain customer demands for our products. COVID-19 could also negatively impact the operations of our third-party manufacturing and logistics partners, resulting in an adverse impact to our ability to meet customer demand. Disruption to our supply chain and manufacturing and logistics partners is not limited to COVID-19, as other factors beyond our control could also result in a negative impact to our financial performance and condition.
Exhibit Number |
|
Document |
10.1 |
|
|
10.2 |
|
|
10.3 |
|
|
31.1 |
|
Rule 13a-14(a) Certification of the Chief Executive Officer. |
31.2 |
|
Rule 13a-14(a) Certification of the Chief Financial Officer. |
32.1* |
|
|
101.INS |
|
XBRL Instance Document. |
101.SCH |
|
XBRL Taxonomy Extension Schema Document. |
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document. |
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document. |
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document. |
|
* |
Furnished, not filed. |
23
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SCOTT’S LIQUID GOLD-INC. |
|||
By: |
|
/s/ Mark E. Goldstein |
|
|
|
Mark E. Goldstein |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
|
By: |
|
/s/ Kevin A. Paprzycki |
|
|
|
Kevin A. Paprzycki |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial and Chief Accounting Officer) |
Date: August 11, 2020
24